Fig. 1From: Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: the ABLATIVE-2 trial—a study protocolOverview of outcome measurements. Time points counted from radiotherapy treatment. Legend: w weeks, m months, y years. *questionnaires include evaluation of cosmetic outcomes and quality of lifeBack to article page